Catalyst Wire Dossier Catalyst Wire Dossier

Chiglitazar

Chiglitazar · Chipscreen Biosciences, Ltd.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Chiglitazar, covering 2019-10-25 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets [NA]

See pricing